What does DLH Holdings do and what are its main business segments?

What guidance did DLH Holdings's management provide for the next earnings period?

What is DLH Holdings's latest dividend and current dividend yield?

What were the key takeaways from DLH Holdings's earnings call?

What were the key takeaways from DLH Holdings’s earnings call?

What is the market's earnings forecast for DLH Holdings next quarter?

What factors drove the changes in DLH Holdings's revenue and profit?

What is the revenue and EPS growth rate for DLH Holdings year over year?

- **Revenue Decline**: Q3 revenue fell 17% YoY to $83.3M due to government contract transitions and scope narrowing.
- **Debt Reduction**: Reduced debt by $9.4M to $142.3M, a year ahead of schedule, with 50-55% of EBITDA allocated to debt repayment.
- **Federal Alignment**: Positioning for growth in AI, cybersecurity, and cloud computing, with optimism for 2026 recovery.
- **Challenges**: Slowed RFP flow and contract awards due to government workforce cuts, but expecting stabilization in Q4.

**【CEO Summary Section】**
- **Revenue Erosion**: Q3 revenue declined to $83.3M (vs. $100.7M YoY) due to unbundling and small business set-asides, including $8.5M from VA and $3.2M from DoD. Scope narrowing reduced revenue by $2.2M.
- **Administrative Challenges**: New administration delays funding approvals, slowing contract awards and pipeline conversion. RFP flow and proposal submissions ($25M+ and $100M+) were lower than expected.
- **Financial Resilience**: Reduced debt by $9.4M to $142.3M, a year ahead of schedule. Generated $9.5M in operating cash flow, improving DSO to 46 days.
- **Strategic Focus**: Aligning with federal tech priorities (AI, cybersecurity, cloud) and preparing for potential 2026 recovery. Optimistic about administrative reforms accelerating contract approvals.

**【CFO Financial Commentary】**
- **Earnings Performance**: EBITDA of $8.1M (9.7% of revenue) vs. $10M last year. Non-GAAP metrics reflect cost management amid lower revenue.
- **Debt Management**: Converted 50-55% of EBITDA to debt repayment, reducing leverage. $50M revolver provides liquidity flexibility.
- **Cash Flow Efficiency**: Year-to-date operating cash flow of $12.5M, supporting debt reduction and balance sheet strength.

**【Q&A Highlights】**
- **VA Transition**: Mail order pharmacy program transitioning to small businesses, slower than anticipated but ongoing. Leavenworth site transition on track for August 31.
- **Government Workforce Impact**: Administration cuts in acquisition workforce delayed RFPs and contract awards. Some recovery in workforce stability expected.
- **Outlook**: Anticipate Q4 stabilization and strong 2026 growth driven by federal tech initiatives and administrative reforms.

DLH (DLHC)-7 Aug 25-2025 Q3 Earnings call transcript

- **Revenue & Margin Resilience**: Q2 revenue down 12% YoY but stable sequentially; EBITDA margin improved to 10.5%, driven by cost control.
- **Debt Reduction Momentum**: $15.3M debt paydown in Q2, with 50-55% EBITDA utilization for repayment by year-end.
- **CMOP Contract Tailwind**: Remaining five sites to contribute $23-25M/Q in Q3/Q4, offsetting prior set-aside losses.
- **Naval Growth Catalyst**: $76M Navy contract expanding with shipboard updates, potential FY2026 Virginia/San Diego expansion.
- **Pipeline Strength**: $3.5B new business pipeline with heightened Q3 bid activity, despite admin-induced delays.

**【CEO Summary Section】**
- Revenue for Q2 FY2025 was $89.2 million, down 12% YoY due to small business set-aside conversions and CMOP contract reductions. Sequentially, revenue remained stable compared to Q1.
- EBITDA was $9.4 million, reflecting a 10.5% margin, up from 10.1% YoY. Debt reduced by $15.3 million to $151.7 million, with all mandatory payments made through Q1 2026.
- New business pipeline remains robust at $3.5 billion, with heightened bid activity in Q3. Key wins include AI/ML research contracts for the U.S. Army Medical Command.
- Government budget stability under the continuing resolution supports operations, though delays in contract awards persist due to administrative changes.

**【CFO Financial Commentary】**
- Q2 operating cash flow of $14.5 million drove debt reduction, with $146 million outstanding as of the call date. EBITDA utilization for debt repayment is expected to reach 50-55% by FY2025 end.
- CMOP-related revenue decline of $11.8 million in Q2, with five remaining sites under management through October 2025. Extended contracts may push into FY2026.
- Indirect cost management maintained margins despite lower revenue, with EBITDA as a % of revenue improving to 10.5%.
- Risk from government program terminations remains limited, with negligible impact to core technology services.

**【Q&A Key Takeaways】**
- **CMOP Contract Outlook**: Remaining five sites expected to contribute $23-25 million quarterly in Q3/Q4, with potential extensions into FY2026.
- **NIH Impact**: No direct involvement in terminated studies, but cautious on research grant funding shifts. Core NIH contracts remain stable.
- **Small Business Set-Asides**: Headwinds from prior admin policies easing, with some contracts paused under new admin priorities.
- **Navy Contract Growth**: $76 million award expanding with shipboard software updates, with potential FY2026 expansion in Virginia and San Diego.
- **Future RFPs**: $1 billion+ pipeline in bid phase, delayed by admin procurement consolidation and staffing changes.

DLH (DLHC)-8 May 25-2025 Q2 Earnings call transcript

- **Revenue Decline Drivers**: $5M from small business set-aside conversions, $2M from delayed services, and $1.5M from international exit.
- **Growth Catalysts**: $4B pipeline with >$100M opportunities, new IDIQ wins (e.g., Oasis), and InfiniByte Cloud 2.0 development.
- **Financial Health**: EBITDA down 11% YoY but improving cost control; expect Q2+ cash flow to reduce debt by 50-55% of EBITDA.
- **Key Risks**: Ongoing small business set-aside erosion, international exit completion, and budget uncertainty under CR.

**【CEO Summary Section】**
- **Revenue and EBITDA Performance**: Q1 2025 revenue was $90.8 million, down 7% YoY, driven by $5 million in small business set-aside conversions and $2 million in delayed service timing. EBITDA was $9.9 million (11% margin), down 11% YoY due to lower revenue and cost scaling.
- **Organic Growth Strategy**: Focused on winning high-value contracts leveraging digital transformation, cybersecurity, and systems engineering. Pipeline includes ~$4 billion in qualified bids, with several >$100M opportunities expected to offset small business set-aside erosion.
- **Key Wins**: Awarded C6ISR and IT services contract for Navy, expanding info warfare portfolio. Won Oasis IDIQ, positioning for task order growth in health and readiness markets.
- **Cash Flow and Debt**: Used $11.5M in operating cash due to receivables growth, increasing debt to $167M. Expect Q2+ cash generation to drive deleveraging, targeting 50-55% of EBITDA for debt repayment.
- **Risks**: Small business set-aside conversions (e.g., $7M/quarter CMOP site transitioned in Q1) and international work exit (~$1.5M YoY decline). FY25 may see continued contract unbundling impacts.

**【CFO Financial Commentary】**
- **Revenue Breakdown**: $3.5M loss from unbundled DoD contract, $1.5M from winding down small business acquisitions, $1.5M from international exit, and $2M timing delays.
- **Cost Management**: Reduced variable costs with lower revenue, but fixed cost leverage limited. SG&A up $800K for growth investments (e.g., InfiniByte Cloud 2.0 development).
- **Debt Update**: Current debt ~$161M (down from $167M Q1 end). Amended credit facility provides flexibility for working capital and growth initiatives.
- **Cash Outlook**: Q2 collections improving; expect Q2+ cash flow to offset Q1 shortfall and reduce debt.

**【Q&A Highlights】**
1. **Small Business Set-aside Impact**: Ranked impacts as: (1) $3.5M unbundled DoD contract (low-margin), (2) $1.5M small business tailwind, (3) $1.5M international exit, (4) $2M service timing delays.
2. **InfiniByte Cloud 2.0**: Investing in FedRAMP-compliant platform for secure AI/ML in healthcare. Expected to align with CMMC regulations for future contracts.
3. **CMOP Bidding**: Partnering with small businesses on remaining 4/7 CMOP sites; success would maintain subcontractor role but limit margin upside.
4. **Budget Uncertainty**: Operating under CR with appropriated programs insulated from shutdown risk. Most pipeline opportunities recurring, reducing new award dependency.

DLHC

DLHC fundamentals

Earnings Call

You can ask Aime